Comments

Terns Pharma

TERNNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$9.00
0.030.33%
Last update: 8:44 AM
15 minutes delayed
Terns Pharma (TERN) ForecastNewsEarningsGuidanceDividendsAnalyst Ratings

Insider Trades

Short Interest

Terns Pharma (NASDAQ:TERN) Stock, Insider Trading Activity

Terns Pharma: Insider buying and selling updated today.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Terns Pharmaceuticals Inc Insiders Doing?

At Terns Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 112.33K shares worth $1.12M, meanwhile, insiders have report no purchases in the last 30 days.

Notable Recent Insider Buys and Sales

  • On June 4, 2024, Seokho Bryan Yoon, the company's COO AND GENERAL COUNSEL purchased 4.79K shares for $4.44 each.
  • On June 4, 2024, Mark J Vignola, the company's CHIEF FINANCIAL OFFICER purchased 4.79K shares for $4.44 each.
  • On July 17, 2024, Carl L Gordon, the company's DIRECTOR sold 56.16K shares for $10 each.

Ownership Statistics for Terns Pharmaceuticals Inc

Institutional Shares Held
15.542M
Institutional Percentage Held
24.0%
Jul 17, 2024Carl L GordonDIRECTOR-56.16K$10.00-$561.64KSELL-6.92%755.63KJul 15 - Jul 16View
Jul 17, 2024ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdOrbiMed Genesis GP LLCDIRECTOR-56.16K$10.00-$561.64KSELL-6.92%755.63KJul 15 - Jul 16View
Jul 17, 2024Jill M Quigley—0.00$5.91-$120.79KSELL-OPTIONS0.00%30.00KJul 15 - Jul 16View
Jun 04, 2024Seokho Bryan YoonCOO AND GENERAL COUNSEL4.79K$4.44$21.27KBUY5.50%91.94KMay 31View
Jun 04, 2024Mark J VignolaCHIEF FINANCIAL OFFICER4.79K$4.44$21.27KBUY5.50%91.94KMay 31View
Apr 03, 2024Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP10% OWNER-420.66K$6.65-$2.80MSELL-61.03%268.57KApr 01 - Apr 03View
Dec 04, 2023Seokho Bryan YoonCOO AND GENERAL COUNSEL743.00$3.78$2.81KBUY4.21%18.40KNov 30View
Dec 04, 2023Mark J VignolaCHIEF FINANCIAL OFFICER743.00$3.78$2.81KBUY4.21%18.40KNov 30View
Jun 02, 2023Mark J VignolaCHIEF FINANCIAL OFFICER10.00K$1.41$14.10KBUY130.53%17.66KMay 31View
Jun 02, 2023Seokho Bryan YoonCOO AND GENERAL COUNSEL10.00K$1.41$14.10KBUY130.53%17.66KMay 31View
Jun 02, 2023Senthil SundaramCHIEF EXECUTIVE OFFICER2.11K$1.41$2.98KBUY27.56%9.77KMay 31View
Feb 03, 2023Seokho Bryan YoonCOO AND GENERAL COUNSEL3.00$1.41$4.23BUY0.04%7.66KNov 30View
Feb 03, 2023Mark J VignolaCHIEF FINANCIAL OFFICER3.00$1.41$4.23BUY0.04%7.66KNov 30View
Feb 03, 2023Senthil SundaramCHIEF EXECUTIVE OFFICER3.00$1.41$4.23BUY0.04%7.66KNov 30View
Dec 28, 2022ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdOrbiMed Genesis GP LLCDIRECTOR137.93K$7.25$1000.00KBUY2.50%5.65MDec 23View
Dec 28, 2022Carl L GordonDIRECTOR137.93K$7.25$1000.00KBUY2.50%5.65MDec 23View
Dec 23, 2022Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP10% OWNER758.62K$7.25$5.50MBUY19.64%4.62MDec 23View
Dec 23, 2022Hongbo Lu—758.62K$7.25$5.50MBUY21.18%4.34MDec 23View
Nov 28, 2022LAV Biosciences Fund V LPHopewell Resources Holdings LtdLAV Aqua LtdOriental Spring Venture Ltd10% OWNER-1.50M$5.50-$8.25MSELL-45.23%1.82MNov 23View
Sep 08, 2022Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP10% OWNER600.00K$3.60$2.16MBUY18.39%3.86MSep 07View
Sep 08, 2022Hongbo Lu—600.00K$3.60$2.16MBUY20.12%3.58MSep 07View
Aug 18, 2022ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdOrbiMed Genesis GP LLCDIRECTOR3.69M$2.42$8.93MBUY∞762.40KAug 16View
Aug 18, 2022Carl L GordonDIRECTOR3.69M$2.42$8.93MBUY∞762.40KAug 16View
Aug 16, 2022Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP10% OWNER2.62M$2.66$6.98MBUY410.95%3.26MAug 12 - Aug 16View
Aug 16, 2022Hongbo Lu—2.62M$2.66$6.98MBUY734.35%2.98MAug 12 - Aug 16View
Jun 08, 2022Seokho Bryan YoonCOO AND GENERAL COUNSEL7.66K$1.47$11.25KBUY∞7.66KMay 31View
Jun 08, 2022Mark J VignolaCHIEF FINANCIAL OFFICER7.66K$1.47$11.25KBUY∞7.66KMay 31View
Jun 08, 2022Senthil SundaramCHIEF EXECUTIVE OFFICER7.66K$1.47$11.25KBUY∞7.66KMay 31View
Feb 09, 2021Carl GordonDIRECTOR3.79M$17.00$8.07MBUY∞2.27MFeb 09View
Feb 09, 2021ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdDIRECTOR3.79M$17.00$8.07MBUY∞2.27MFeb 09View
Feb 09, 2021Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LPVivo Opportunity LLCVivo Opportunity Fund LP10% OWNER2.68M$17.00$8.07MBUY∞357.35KFeb 09View
Feb 09, 2021James FlynnDEERFIELD MANAGEMENT COMPANY LP SERIES CDEERFIELD PARTNERS LPDeerfield Mgmt LP10% OWNER2.38M$17.00$11.30MBUY∞2.38MFeb 09View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch